However, for HER2-enriched BC, patients aged ≤ 45 years had significantly higher TIL density than patients in the other age groups (vs. 46–60 years: P = 0.002, and vs. ≥ 61 years: P = 0.018). This evidence concerns the gene ERBB2 and breast cancer.